Telomerase detection in body fluids
- PMID: 11751534
Telomerase detection in body fluids
Abstract
Background: Telomerase is a ribonucleoprotein that maintains chromosomal telomere length. Telomerase is not active in nonmalignant somatic cells, but is activated in most human cancers. Telomerase activity in easily obtainable body fluids that bathe tumors may be a useful cancer marker, especially when used in conjunction with conventional cytology.
Approach: Results from studies that assayed telomerase activity in easily obtainable body fluids are reviewed.
Content: The telomerase repeat amplification protocol (TRAP) assay has been used to measure telomerase activity in body fluids, including ascites, pleural effusions, pelvic washes, bronchial washings, bronchial lavage, urine, bladder washings, oral rinses, and plasma. Telomerase activity has sensitivities of 60-90% as a tumor marker with clinical specificities for cancer of approximately 90%. Telomerase activity is more sensitive than conventional cytology, the sensitivity of which was 40-65% in various studies.
Summary: Telomerase activity in body fluids, as measured by the TRAP assay, is a sensitive potential tumor marker that might help increase the cancer detection rate and the cancer treatment success rate when combined with conventional cytology.
Similar articles
-
Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients.Int J Mol Med. 2005 Nov;16(5):857-63. Int J Mol Med. 2005. PMID: 16211255
-
Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer.Eur J Cardiothorac Surg. 2003 Feb;23(2):194-9; discussion 199-20. doi: 10.1016/s1010-7940(02)00741-8. Eur J Cardiothorac Surg. 2003. PMID: 12559342
-
The clinical implications of telomerase activity in upper tract urothelial cancer and washings.BJU Int. 2000 Aug;86(3):213-9. doi: 10.1046/j.1464-410x.2000.00830.x. BJU Int. 2000. PMID: 10930917
-
Prevalence of telomerase activity in human cancer.J Formos Med Assoc. 2011 May;110(5):275-89. doi: 10.1016/S0929-6646(11)60043-0. J Formos Med Assoc. 2011. PMID: 21621148 Review.
-
Detection of telomerase activity by the TRAP assay and its variants and alternatives.Clin Chim Acta. 2006 Sep;371(1-2):25-31. doi: 10.1016/j.cca.2006.02.039. Epub 2006 Apr 17. Clin Chim Acta. 2006. PMID: 16616059 Review.
Cited by
-
Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells.J Mol Diagn. 2004 Aug;6(3):157-65. doi: 10.1016/S1525-1578(10)60506-5. J Mol Diagn. 2004. PMID: 15269291 Free PMC article.
-
Targeting telomerase-expressing cancer cells.J Cell Mol Med. 2011 Jul;15(7):1433-42. doi: 10.1111/j.1582-4934.2011.01279.x. J Cell Mol Med. 2011. PMID: 21332640 Free PMC article. Review.
-
Is telomerase a viable target in cancer?Mutat Res. 2012 Feb 1;730(1-2):90-7. doi: 10.1016/j.mrfmmm.2011.07.006. Epub 2011 Jul 23. Mutat Res. 2012. PMID: 21802433 Free PMC article. Review.
-
Telomeres, telomerase and colorectal cancer.World J Gastroenterol. 2014 Feb 28;20(8):1940-50. doi: 10.3748/wjg.v20.i8.1940. World J Gastroenterol. 2014. PMID: 24616570 Free PMC article. Review.
-
Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation.World J Gastroenterol. 2007 Jun 14;13(22):3122-7. doi: 10.3748/wjg.v13.i22.3122. World J Gastroenterol. 2007. PMID: 17589931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources